Cargando…

Pivotal Shigella Vaccine Efficacy Trials—Study Design Considerations from a Shigella Vaccine Trial Design Working Group

Vaccine candidates for Shigella are approaching phase 3 clinical trials in the target population of young children living in low- and middle-income countries. Key study design decisions will need to be made to maximize the success of such trials and minimize the time to licensure and implementation....

Descripción completa

Detalles Bibliográficos
Autores principales:	Pavlinac, Patricia B., Rogawski McQuade, Elizabeth T., Platts-Mills, James A., Kotloff, Karen L., Deal, Carolyn, Giersing, Birgitte K., Isbrucker, Richard A., Kang, Gagandeep, Ma, Lyou-Fu, MacLennan, Calman A., Patriarca, Peter, Steele, Duncan, Vannice, Kirsten S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032541/ https://www.ncbi.nlm.nih.gov/pubmed/35455238 http://dx.doi.org/10.3390/vaccines10040489

Ejemplares similares

The Shigella Vaccines Pipeline
por: MacLennan, Calman Alexander, et al.
Publicado: (2022)

Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries
por: Giersing, Birgitte K, et al.
Publicado: (2023)

Frontiers in Shigella Vaccine Development
por: MacLennan, Calman Alexander, et al.
Publicado: (2022)

Critical Needs in Advancing Shigella Vaccines for Global Health
por: MacLennan, Calman A, et al.
Publicado: (2021)

Consequences of Shigella infection in young children: a systematic review
por: Libby, Tanya E., et al.
Publicado: (2023)

Threshold protective levels of serum IgG to Shigella lipopolysaccharide: re-analysis of Shigella vaccine trials data
por: Cohen, Dani, et al.
Publicado: (2023)

Could a Shigella vaccine impact long-term health outcomes?: Summary report of an expert meeting to inform a Shigella vaccine public health value proposition, March 24 and 29, 2021
por: Bagamian, Karoun H., et al.
Publicado: (2022)

What Drives the Value of a Shigella Vaccine?
por: Hausdorff, William P., et al.
Publicado: (2022)

Consensus Report on Shigella Controlled Human Infection Model: Introduction and Overview
por: MacLennan, Calman A, et al.
Publicado: (2019)

Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints
por: MacLennan, Calman A, et al.
Publicado: (2019)

Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies
por: Talaat, Kawsar R, et al.
Publicado: (2019)

Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy
por: Hosangadi, Divya, et al.
Publicado: (2019)

An O Antigen Capsule Modulates Bacterial Pathogenesis in Shigella sonnei
por: Caboni, Mariaelena, et al.
Publicado: (2015)

Consensus Report on Shigella Controlled Human Infection Model: Immunological Assays
por: Kaminski, Robert W, et al.
Publicado: (2019)

Salmonella Combination Vaccines: Moving Beyond Typhoid
por: MacLennan, Calman A, et al.
Publicado: (2023)

A clinically parameterized mathematical model of Shigella immunity to inform vaccine design
por: Davis, Courtney L., et al.
Publicado: (2018)

Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–2016
por: Khalil, Ibrahim A, et al.
Publicado: (2018)

Correction: A clinically parameterized mathematical model of Shigella immunity to inform vaccine design
por: Davis, Courtney L., et al.
Publicado: (2018)

Recent Progress in Shigella and Burkholderia pseudomallei Vaccines
por: Chapartegui-González, Itziar, et al.
Publicado: (2021)

The Ongoing Journey of a Shigella Bioconjugate Vaccine
por: Martin, Patricia, et al.
Publicado: (2022)

The Clinical Presentation of Culture-positive and Culture-negative, Quantitative Polymerase Chain Reaction (qPCR)-Attributable Shigellosis in the Global Enteric Multicenter Study and Derivation of a Shigella Severity Score: Implications for Pediatric Shigella Vaccine Trials
por: Pavlinac, Patricia B, et al.
Publicado: (2020)

Shigella in Africa: New Insights From the Vaccine Impact on Diarrhea in Africa (VIDA) Study
por: Kasumba, Irene N, et al.
Publicado: (2023)

Shigella Outer Membrane Vesicles as Promising Targets for Vaccination
por: Qasim, Muhammad, et al.
Publicado: (2022)

Immunization of Rabbits with a Quadrivalent Shigella Bioconjugate Vaccine Induces Functional Antibodies Reactive with Shigella Isolates from Kenya
por: Odundo, Elizabeth A., et al.
Publicado: (2022)

Incidence and etiology of clinically-attended, antibiotic-treated diarrhea among children under five years of age in low- and middle-income countries: Evidence from the Global Enteric Multicenter Study
por: Lewnard, Joseph A., et al.
Publicado: (2020)

Shigella sonnei
por: Torraca, Vincenzo, et al.
Publicado: (2020)

Clinical Trial of an Oral Live Shigella sonnei Vaccine Candidate, WRSS1, in Thai Adults
por: Pitisuttithum, Punnee, et al.
Publicado: (2016)

Shigella conjugate vaccine efficacy trial in controlled human model and potential immune correlates of protection
por: Raqib, Rubhana, et al.
Publicado: (2021)

Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine
por: Rogawski McQuade, Elizabeth T, et al.
Publicado: (2021)

Epidemiology of Shigella infections and diarrhea in the first two years of life using culture-independent diagnostics in 8 low-resource settings
por: Rogawski McQuade, Elizabeth T., et al.
Publicado: (2020)

Vaccines for the prevention of diarrhea due to cholera, shigella, ETEC and rotavirus
por: Das, Jai K, et al.
Publicado: (2013)

The identification of novel immunogenic antigens as potential Shigella vaccine components
por: de Alwis, Ruklanthi, et al.
Publicado: (2021)

Shigella Isolates From the Global Enteric Multicenter Study Inform Vaccine Development
por: Livio, Sofie, et al.
Publicado: (2014)

In vitro adhesion and invasion inhibition of Shigella dysenteriae, Shigella flexneri and Shigella sonnei clinical strains by human milk proteins
por: Willer, Emerson da Motta, et al.
Publicado: (2004)

T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans
por: Toapanta, Franklin R., et al.
Publicado: (2018)

Evaluation of an intragastric challenge model for Shigella dysenteriae 1 in rhesus monkeys (Macaca mulatta) for the pre-clinical assessment of Shigella vaccine formulations
por: Islam, Dilara, et al.
Publicado: (2014)

Effect of Wild-Type Shigella Species and Attenuated Shigella Vaccine Candidates on Small Intestinal Barrier Function, Antigen Trafficking, and Cytokine Release
por: Fiorentino, Maria, et al.
Publicado: (2014)

Systems approach to define humoral correlates of immunity to Shigella
por: Bernshtein, Biana, et al.
Publicado: (2022)

Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes
por: Citiulo, Francesco, et al.
Publicado: (2021)

Pathogenicity of Shigella in Chickens
por: Shi, Run, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_noljk3bp8r79n7q1viul09cfu6